Our Medical Director

Robert Dracker MD, MHA, MBA, CPI

Medical Director Dr. Dracker received his B.A in Biology from NYU, graduating Phi Beta Kappa, and subsequently attended medical school at the SUNY Health Science Center at Syracuse, where he also graduated Alpha Omega Alpha with honors.

He completed a residency in Pediatrics and fellowships in Pediatric Hematology/Oncology and in Blood Banking/Transfusion Medicine, all at University Hospital in Syracuse. Dr. Dracker later obtained a Master's degree in Health Services Management (MHA) from the New School for Social Research and an MBA from Columbia College in 2007.

He is board certified in Pediatrics, Transfusion Medicine, and as a Certified Physician Investigator. Dr. Dracker is also certified in Managed Care Medicine and in Quality Assurance and Utilization Review, with sub board certification in managed care review. He is also a certified Advanced Biotherapies Profession involved with the area of Cellular Therapy and Transplantation.

Dr. Dracker is currently President of the Onondaga County Medical Society from November 2021 through November 2023. Dr. Dracker served as Medical Director of the Transfusion Medicine Service at University Hospital for five years prior to his current position as founder and Medical Director of Summerwood Pediatrics (previously known as North Area Pediatrics) since 1993, with his primary office location in Liverpool. He also founded Infusacare Medical Services, which provides adult and pediatric patients with currently standard and emerging outpatient intravenous therapies.

Dr. Dracker has been actively involved in the area of cord blood banking and stem cell transplant. He was the medical director of The Biocyte Corporation, which facilitated the first cord blood transplant in the United States, and was the Medical Director of ViaCord in Cambridge, Massachusetts, up until May of 2007. He is currently the Executive Medical Director of Americord, based in New York City.

Dr. Dracker served on the NYS Governor's Council for Blood and Transfusion Services for 17 years and has been the Chairperson and was a member of the Hematopoietic Progenitor Cell Committee for the New York State Department of Health, as well as the Chairman of the Heart, Lung and Cancer Committee for the Medical Society of the State of New York. He also served as a member of the Pediatric Advisory Committee of the FDA. For the past 11 years, of which he currently chairs.

Dr. Dracker serves on a number professional and charitable boards and has presented worldwide on many topics regarding pharmaceutical parental therapies, clinical research and a variety of pediatric policies and stem cell therapy. He is actively involved in ongoing basic science and clinical research, particularly involving vaccine therapies, and has well over 50 abstract and article publications.

Dr. Dracker's Forbes Health Profile